InvestorsHub Logo
Followers 28
Posts 2133
Boards Moderated 0
Alias Born 06/15/2007

Re: manibiotech post# 251733

Thursday, 11/14/2019 8:37:02 PM

Thursday, November 14, 2019 8:37:02 PM

Post# of 700308
Everyone is allowed to interpret what they wish from 10q or a conversation with an officer of a company

What can’t be denied is the that patients who received DCVAX are living significantly longer than patients on the SOC for this trial and historical SOC in other trials

All the other stuff is a diversion from the goal


The company has to rewrite a SAP to attempt to explain what happened with crossover patients , and other subgroup PTS methylated , unmethylated , SOC , SOC crossover / methylated crossovers unmethylated crossovers

These subgroups on their own can’t yield a stat sig for anyone group

But the totality of the stats for OS is likely what the SAP will try to explain

Considering that they have struggled to raise money hopefully the unblind occurs soon so they don’t have to keep diluting 10-20m shares at a time

Marzan thoughts on $AMRN Maybe u can finance the next bandaid for Linda
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News